We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Turning the Virus’ RBD Into a Nanoparticle an Appealing Approach for COVID-19 Vaccine

News   Oct 29, 2020 | Original story from University at Buffalo

 
Turning the Virus’ RBD Into a Nanoparticle an Appealing Approach for COVID-19 Vaccine

A close-up view of the RBD particle vaccine (green). Credit: Facility for Electron Microscopy Research (FEMR) at McGill University.

 
 
Advertisement
 

RELATED ARTICLES

"Z-Drugs" for Dementia Linked to Adverse Side Effects

News

A new study reveals that stronger doses of these drugs are linked with an increased risk of adverse effects.

READ MORE

Early- and Late-Stage Neurodegeneration May Require Bespoke Treatments

News

Rice University biochemists have studied how neurodegeneration kills cells.

READ MORE

Targeting Calcium Overload Could Improve Stroke Outcomes

News

Researchers have established that excessive calcium contributes to harmful inflammation in ischemic stroke, and targeting it may provide doctors with a new way to improve patient outcomes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE